Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

NCT00939510 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: sargramostim
DRUG: lenalidomide
OTHER: laboratory biomarker analysis

Sponsor

Robert Dreicer MD

Collaborators

[object Object]